Pharmafile Logo
Pharmafocus logo
Advanced Search

myeloma

Showing 3 posts of 33 posts found.

Celgene image

Celgene’s multiple myeloma pill launched in UK

August 15, 2013
Sales and Marketing Celgene, Velcade, low, myeloma

Celgene’s new oral blood cancer drug pomalidomide has been launched in the UK and Ireland as a third line treatment …

News
NICEweb

Thalidomide recommended ahead of Velcade

June 2, 2010
Medical Communications NICE, myeloma

Celgene’s Thalidomide has been recommended by NICE as a treatment for multiple myeloma, and is favoured ahead of Janssen-Cilag’s Velcade. …

News

Boehringer signs antibody myeloma R&D deal

May 10, 2010
Research and Development Boehringer, Cancer, Micromet, myeloma

Boehringer Ingelheim and US biotech company Micromet are to research and develop a new BiTE antibody to treat multiple myeloma. …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025